Company: SNSE
Filing Date: 2025-10-30
Form Type: 8-K
Source: 0001193125-25-257621
Chunk: 0

Company: Sensei Biotherapeutics, Inc.
Filing Date: 2025-10-30
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item 7.01 Regulation FD Disclosure.

On October 30, 2025, Sensei Biotherapeutics, Inc. (the “ Company”) issued a press release titled “ Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value”. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in Item 7.01 and the exhibit attached hereto are being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that section, nor shall they be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, whether filed before or after the date hereof and regardless of any general incorporation language in such filing.